Cellectar Biosciences Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option
August 20, 2014 at 16:07 PM EDT
Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection ...